Drug Trial Radar · NCT06590896
Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
Last checked: Nov 19, 2026Latest source record: Jun 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Nov 4, 2022
Primary completion
Jan 31, 2027
Study completion Jan 31, 2027
Sponsor
- Lead sponsor
- Ono Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures
Conditions
- Epilepsies, Partial
Interventions
CenobamateDrug
Cenobamate will be orally administered once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidences of Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: Through study completion, an average of 4 years
- Urinalysis(pH)Time frame: Through study completion, an average of 4 years
- Urinalysis(Specific Gravity)Time frame: Through study completion, an average of 4 years
- Urinalysis(Protein)Time frame: Through study completion, an average of 4 years
- Urinalysis(Glucose)Time frame: Through study completion, an average of 4 years
- Urinalysis(Ketone)Time frame: Through study completion, an average of 4 years
- Urinalysis(Bilirubin)Time frame: Through study completion, an average of 4 years
- Urinalysis(Blood)Time frame: Through study completion, an average of 4 years
- Urinalysis(Nitrite)Time frame: Through study completion, an average of 4 years
- Urinalysis(Urobilinogen)Time frame: Through study completion, an average of 4 years
- Urinalysis( Microscopic Examination)Time frame: Through study completion, an average of 4 years
- Liver function tests(total protein)Time frame: Through study completion, an average of 4 years
- Liver function tests(albumin)Time frame: Through study completion, an average of 4 years
- Liver function tests(total bilirubin)Time frame: Through study completion, an average of 4 years
- Liver function tests(aspartate transaminase)Time frame: Through study completion, an average of 4 years
- Liver function tests(alanine aminotransferase)Time frame: Through study completion, an average of 4 years
- Liver function tests(alkaline phosphatase)Time frame: Through study completion, an average of 4 years
- Liver function tests(gamma-glutamyl transferase)Time frame: Through study completion, an average of 4 years
- Hematology(Hemoglobin)Time frame: Through study completion, an average of 4 years
- Hematology(hematocrit)Time frame: Through study completion, an average of 4 years
- Hematology(white blood cell count)Time frame: Through study completion, an average of 4 years
- Hematology(red blood cell count)Time frame: Through study completion, an average of 4 years
- Hematology(mean corpuscular volume)Time frame: Through study completion, an average of 4 years
- Hematology(mean corpuscular hemoglobin)Time frame: Through study completion, an average of 4 years
- Hematology(red blood cell distribution width)Time frame: Through study completion, an average of 4 years
- Hematology(platelet count)Time frame: Through study completion, an average of 4 years
- Serum chemistry(blood urea nitrogen)Time frame: Through study completion, an average of 4 years
- Serum chemistry(calcium)Time frame: Through study completion, an average of 4 years
- Serum chemistry(chloride)Time frame: Through study completion, an average of 4 years
- Serum chemistry(creatinine)Time frame: Through study completion, an average of 4 years
- Serum chemistry(total bilirubin)Time frame: Through study completion, an average of 4 years
- Serum chemistry(direct bilirubin)Time frame: Through study completion, an average of 4 years
- Serum chemistry(alkaline phosphatase)Time frame: Through study completion, an average of 4 years
- Serum chemistry(alanine aminotransferase)Time frame: Through study completion, an average of 4 years
- Serum chemistry(gamma-glutamyl transferase)Time frame: Through study completion, an average of 4 years
- Serum chemistry(total protein)Time frame: Through study completion, an average of 4 years
- Serum chemistry(albumin)Time frame: Through study completion, an average of 4 years
- Serum chemistry(globulin)Time frame: Through study completion, an average of 4 years
- Serum chemistry(sodium)Time frame: Through study completion, an average of 4 years
- Serum chemistry(potassium)Time frame: Through study completion, an average of 4 years
- Serum chemistry(phosphorus)Time frame: Through study completion, an average of 4 years
- Serum chemistry(glucose)Time frame: Through study completion, an average of 4 years
- Heart rateTime frame: Through study completion, an average of 4 years
- Respiratory RateTime frame: Through study completion, an average of 4 years
- Blood PressureTime frame: Through study completion, an average of 4 years
- Electrocardiogram (ECG) FindingsTime frame: Through study completion, an average of 4 years
- Columbia-Suicide Severity Rating Scale (C-SSRS) ScoresTime frame: Through study completion, an average of 4 years
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
Ehime University Hospital
Ehime, Japan · Recruiting
Department of Neurology and Stroke Center, Southern Tohoku Clinic.
Fukushima, Japan · Recruiting
Hiroshima University Hospital
Hiroshima, Japan · Recruiting
NHO Kure Medical Center and Chugoku Cancer Center
Hiroshima, Japan · Recruiting
Asahikawa Medical University Hospital
Hokkaido, Japan · Recruiting
Itami City Hospital
Hyōgo, Japan · Recruiting
JA-Ibaraki Tsuchiura Kyodo General Hospital
Ibaraki, Japan · Recruiting
University of Tsukuba Hospital
Ibaraki, Japan · Recruiting
Kagoshima University Hospital
Kagoshima, Japan · Recruiting
Tanaka Neurosurgical Clinic
Kagoshima, Japan · Recruiting
St. Marianna University School of Medicine Hospital
Kanagawa, Japan · Recruiting
Yokohama City University Hospital
Kanagawa, Japan · Recruiting
Kumamoto Ezuko Rehabilitation Medical Center
Kumamoto, Japan · Recruiting
NHO Nagasaki Medical Center
Nagasaki, Japan · Recruiting
Koide Clinic of Epilepsy and Neurological Disorders
Osaka, Japan · Recruiting
Osaka University Hospital
Osaka, Japan · Recruiting
Shintokukai Nii Neurosurgery and Psychiatry Clinic
Osaka, Japan · Recruiting
Ochiai Brain Clinic
Saitama, Japan · Recruiting
TMG ASAKA Medical Center
Saitama, Japan · Recruiting
Sakurai Clinic
Shiga, Japan · Recruiting
NHO Shizuoka Institute of Epilepsy and Neurological Disorders
Shizuoka, Japan · Recruiting
Seirei Hamamatsu General Hospital
Shizuoka, Japan · Recruiting
Seirei Mikatahara General Hospital
Shizuoka, Japan · Recruiting
Jichi Medical University Hospital
Tochigi, Japan · Recruiting
Tokushima University Hospital
Tokushima, Japan · Recruiting
Medical Hospital, Tokyo Medical and Dental University
Tokyo, Japan · Recruiting
National Center of Neurology and Psychiatry
Tokyo, Japan · Recruiting
Tokyo Medical University Hospital
Tokyo, Japan · Recruiting
NHO Yamagata National Hospital
Yamagata, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.